Figure 2From: Health-related quality of life advantage of long-acting injectable antipsychotic treatment for schizophrenia: a time trade-off studyFrequency distribution of respondents scores across the four treatment regimens (0.0 = death equivalent health-related quality of life, 1.0 = full health).Back to article page